Takeda Pharmaceutical Company Limited Equity Attributable To Owners Of Parent
Takeda Pharmaceutical Company Limited (TKPHF) had Equity Attributable To Owners Of Parent of JPY 6.94 trillion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:EquityAttributableToOwnersOfParent · last filed 2025-06-25
- 2025-03-31: Equity Attributable To Owners Of Parent 6.94T JPY.
- 2024-03-31: Equity Attributable To Owners Of Parent 7.27T JPY.
- 2023-03-31: Equity Attributable To Owners Of Parent 6.35T JPY.
- 2022-03-31: Equity Attributable To Owners Of Parent 5.68T JPY.
| Period end | Equity Attributable To Owners Of Parent | Equity Attributable To Owners Of Parent as first filed |
|---|---|---|
| 2025-03-31 | 6.94T JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 7.27T JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 6.35T JPY 20-F · filed 2024-06-26 | |
| 2022-03-31 | 5.68T JPY 20-F · filed 2023-06-28 | |
| 2021-03-31 | 5.17T JPY 20-F · filed 2022-06-29 | |
| 2020-03-31 | 4.72T JPY 20-F · filed 2021-06-29 | |
| 2019-03-31 | 5.18T JPY 20-F · filed 2020-06-24 | 5.16T JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 2.00T JPY 20-F · filed 2019-06-27 |